DSGN
Design Therapeutics Inc
NASDAQ: DSGN · HEALTHCARE · BIOTECHNOLOGY
$13.41
+1.82% today
Updated 2026-05-05
Market cap
$822.56M
P/E ratio
—
P/S ratio
29,402.82x
EPS (TTM)
$-1.19
Dividend yield
—
52W range
$3 – $17
Volume
0.4M
Design Therapeutics Inc (DSGN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $90000.00 | $36.52M | $390.56M | $341.14M | $289.64M | $252.09M |
| Cash & equivalents | $77000.00 | $2.38M | $298.57M | $26.50M | $21.20M | $22.56M |
| Current assets | $90000.00 | $36.23M | $385.44M | $335.12M | $284.58M | $248.04M |
| Total liabilities | $3.73M | $47.83M | $8.43M | $13.83M | $11.96M | $10.00M |
| Current liabilities | $3.73M | $2.33M | $5.28M | $10.78M | $9.62M | $8.46M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $-3.64M | $-11.31M | $382.13M | $327.31M | $277.69M | $242.10M |
| Retained earnings | $-3.64M | $-11.92M | $-47.46M | $-110.76M | $-177.63M | $-227.21M |
| Accounts receivable | — | $10000.00 | $110000.00 | $1.11M | $1.43M | $1.26M |
| Inventory | — | $107000.00 | $1.25M | $-1.11M | — | — |
| Goodwill | — | — | — | — | — | — |